ciltacabtagene autoleucel
janssen,legend bio
promising data for early relapse in functionally high risk #myeloma in the absence of traditional hr markers. this study promotes use in earlier lines of therapy. #ims2022 #mmsm 
Hematology is in my blood. Posts are mine. Mayo Clinic MM RN Navigator, IMF MM KOL, educator, patient advocate, medical writer.